Study on Cloning, Expressing and Bioactivity of S-8300's cDNA Fragment

HUANG Feng-jie,L(U) Li-li,QIAN Jing,WU Wu-tong

2010-01-01

Abstract:OBJECTIVE Study on cloning, expressing and bioactivity of a new peptide S-8300. METHODS A deduced oligonueleotide primer was designed according to the N-terminal amino acid residues of the new peptide S-8300. One cDNA segment was amplified from the total RNA of regenerated hepatic tissue using the technique of RT-PCR, and its nucleotides were 342 bp. RESULTS Ac-cording to the result of sequence analysis and derived amino acids sequence, this fragment's amino acid residues had similarity with S-8300 at the end of N-terminal. In this study, the cDNA encoding S-8300 was inserted into the downstream of signal peptide PelB to construct the secretory plasmid pET22b-S which was transformed into Escherichia coli BL21 (DE3) competent cells. Then the prokaryotic secretory expression strain pET22b-S/BL21 (DE3) was constructed. When the induced with O.4 mmol·L~(-1)IPTG at 25 ℃, the recombinant protein rS-8300 was secreted into the periplasm of the engineering strain in a soluble form effectively. CONCLUSION It had the same activities with natural products which could recover the damage of NIT-1 cell after exposed to the toxin of streptozocin.